We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$225B
1-Year Est. Return
49.49%
This Fund
S&P 500
This Quarter
Est. Return
+11.74%
1 Year Est. Return
+49.49%
3 Year Est. Return
+172.58%
5 Year Est. Return
+223.9%
10 Year Est. Return
+876%
AUM
$71.5B
AUM Growth
+$3.66B
(+5.4%)
Cap. Flow
-$2.85B
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
18.22%
Holding
1,538
New
294
Increased
526
Reduced
448
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$268M |
| 2 |
General Motors
GM
|
+$263M |
| 3 |
AstraZeneca
AZN
|
+$235M |
| 4 |
Vale
VALE
|
+$226M |
| 5 |
Oracle
ORCL
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$945M |
| 2 |
Microsoft
MSFT
|
+$606M |
| 3 |
Canadian Natural Resources
CNQ
|
+$552M |
| 4 |
Bank of America
BAC
|
+$490M |
| 5 |
AbbVie
ABBV
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.7% |
| 2 | Healthcare | 20.13% |
| 3 | Consumer Discretionary | 15.62% |
| 4 | Financials | 9.5% |
| 5 | Energy | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Strategic Education
STRA
$1.86B
| $303K | ﹤0.01% |
+3,871
| New | +$287K |
|
|
SNV
1202
DELISTED
Synovus
SNV
| $302K | ﹤0.01% |
8,040
-6,694
| -45% | -$266K |
|
1203
Willis Lease Finance
WLFC
$1.15B
| $301K | ﹤0.01% |
+15,324
| New | +$229K |
|
1204
OneSpaWorld
OSW
$2.73B
| $297K | ﹤0.01% |
+31,793
| New | +$301K |
|
|
DBD
1205
DELISTED
Diebold Nixdorf Incorporated
DBD
| $296K | ﹤0.01% |
+208,768
| New | +$448K |
|
1206
Legend Biotech
LEGN
$3.93B
| $295K | ﹤0.01% |
5,903
-140,184
| -96% | -$6.79M |
|
1207
AMES National
ATLO
$281M
| $292K | ﹤0.01% |
12,387
-3,032
| -20% | -$68.9K |
|
1208
American Eagle Outfitters
AEO
$2.73B
| $291K | ﹤0.01% |
+20,839
| New | +$267K |
|
1209
Innospec
IOSP
$2.31B
| $290K | ﹤0.01% |
+2,819
| New | +$286K |
|
|
RAD
1210
DELISTED
Rite Aid Corporation
RAD
| $290K | ﹤0.01% |
+86,703
| New | +$412K |
|
1211
Greif
GEF
$5.03B
| $288K | ﹤0.01% |
+4,289
| New | +$289K |
|
|
HCP
1212
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $288K | ﹤0.01% |
+10,536
| New | +$298K |
|
1213
DaVita
DVA
$11.4B
| $287K | ﹤0.01% |
+3,846
| New | +$299K |
|
1214
EPAM Systems
EPAM
$5.24B
| $286K | ﹤0.01% |
+872
| New | +$296K |
|
1215
West Pharmaceutical
WST
$24.4B
| $285K | ﹤0.01% |
+1,210
| New | +$287K |
|
|
ENLC
1216
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $285K | ﹤0.01% |
23,187
-189,314
| -89% | -$2.19M |
|
1217
Sensata Technologies
ST
$6.61B
| $281K | ﹤0.01% |
+6,957
| New | +$290K |
|
1218
Associated Banc-Corp
ASB
$6.07B
| $280K | ﹤0.01% |
12,136
-336,509
| -97% | -$7.77M |
|
1219
LPL Financial
LPLA
$29.5B
| $280K | ﹤0.01% |
1,294
-6,758
| -84% | -$1.58M |
|
|
ATSG
1220
DELISTED
Air Transport Services Group
ATSG
| $280K | ﹤0.01% |
10,767
-556
| -5% | -$15.3K |
|
1221
HealthEquity
HQY
$8.83B
| $279K | ﹤0.01% |
+4,526
| New | +$304K |
|
1222
National Bankshares
NKSH
$272M
| $279K | ﹤0.01% |
6,920
| – | – |
|
1223
Elastic
ESTC
$8.94B
| $278K | ﹤0.01% |
+5,407
| New | +$324K |
|
1224
Xerox
XRX
$412M
| $276K | ﹤0.01% |
18,909
-482,428
| -96% | -$7.27M |
|
1225
Korn Ferry
KFY
$4.36B
| $275K | ﹤0.01% |
5,432
-29,137
| -84% | -$1.55M |
|
Similar funds
Arrowstreet Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Arrowstreet Capital held 1,538 positions worth $71.5B, up 5.4% from $67.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $2.85B in Q4 2022, closing 234 positions and reducing 448 holdings. Its most notable exit was AbbVie, an estimated $432M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Gerdau worth $105M.
- Arrowstreet Capital's largest Q4 2022 buy was Gerdau: 23,855,591 shares worth $105M.
- Arrowstreet Capital added most to Visa in Q4 2022, an estimated $268M increase.
- Arrowstreet Capital's biggest Q4 2022 reduction was JPMorgan Chase, cutting an estimated $945M.
- Arrowstreet Capital fully exited AbbVie in Q4 2022, selling an estimated $432M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $71.5B portfolio in Q4 2022.
- Arrowstreet Capital opened 294 new positions and closed 234 in Q4 2022.
- Arrowstreet Capital's portfolio value rose 5.4% quarter-over-quarter to $71.5B.
Based on Arrowstreet Capital's 13F filing for Q4 2022, filed 14 Feb 2023.